Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:organization
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:formedBy |
gptkb:CARES_Act
|
| gptkbp:formedIn |
2020
|
| gptkbp:hasChair |
gptkb:Michael_E._Horowitz
|
| gptkbp:hasMember |
Inspectors General from multiple federal agencies
|
| gptkbp:headquartersLocation |
gptkb:Washington,_D.C.
|
| https://www.w3.org/2000/01/rdf-schema#label |
PRAC
|
| gptkbp:monitors |
federal COVID-19 spending
|
| gptkbp:parentOrganization |
gptkb:Council_of_the_Inspectors_General_on_Integrity_and_Efficiency
|
| gptkbp:purpose |
oversight of COVID-19 relief funds
|
| gptkbp:reportsTo |
gptkb:U.S._Congress
|
| gptkbp:standsFor |
gptkb:Pandemic_Response_Accountability_Committee
|
| gptkbp:website |
https://www.pandemicoversight.gov/
|
| gptkbp:bfsParent |
gptkb:Pharmacovigilance_Risk_Assessment_Committee
|
| gptkbp:bfsLayer |
6
|